EcoDrugPlus

Plasminogen Activator, Tissue Type

Ensembl ID : ENSOPRG00000004480
Gene Symbol: PLAT
1 Cross references
204 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSOPRG00000002354
Gene Symbol: PTAFR
3 Cross references
224 Possible Orthologues:

Platelet Derived Growth Factor Receptor Beta

Ensembl ID : ENSOPRG00000008257
Gene Symbol: PDGFRB
3 Cross references
247 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSOPRG00000012087
Gene Symbol: PLK1
1 Cross references
182 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSOPRG00000012536
Gene Symbol: PLK4
1 Cross references
208 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSOPRG00000011722
Gene Symbol: PARP1
1 Cross references
208 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSOPRG00000013873
Gene Symbol: PARP2
1 Cross references
185 Possible Orthologues:

Poly(Adp-Ribose) Polymerase Family Member 3

Ensembl ID : ENSOPRG00000008739
Gene Symbol: PARP3
1 Cross references
198 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSOPRG00000004471
Gene Symbol: PORCN
1 Cross references
265 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSOPRG00000006963
Gene Symbol: KCNMA1
1 Cross references
284 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily N Member 4

Ensembl ID : ENSOPRG00000009513
Gene Symbol: KCNN4
3 Cross references
187 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 5

Ensembl ID : ENSOPRG00000012197
Gene Symbol: KCNJ5
3 Cross references
205 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).